Male Birth Control Injection Ready In 2020
Indian scientists have announced the production of a contraceptive injection for men. It is expected that after clinical trials have been completed on the drug, the public could start using it within six months.
ON THIS PAGE:
The Indian Council of Medical Research have completed the three rounds of clinical trials for a male contraceptive.
The drug is a polymer that blocks sperm for 13 years. It is delivered while a man is under anesthesia.
Scientists claim that more than 300 clinical trial patients reported no side effects.
The drug is expected in the market within 6 to 7 months after getting the necessary approval from the Indian regulatory body.
The contraceptive, once administered remains effective for 13 years before it loses potency. The drug has been sent to the national Drug Controller General of India for final approval.
What remains for it to be available to the public is just regulatory approvals with the Drugs Controller, said Dr Sharma, Senior Scientist with Indian Council of Medical Research
It is made up of a polymer called Steryene Maleic Anhydride developed in the 70s that inhibits sperm production. If approved, the injection will be the first ever male contraceptive and will serve as an alternative to a vasectomy.
The polymer, known as reversible inhibition of sperm under guidance (RISUG) is then injected into the vas deferens, the tubule that delivers sperm from the testes to the penis where it is released in ejaculate.
Dr Sharma has been working on the drug for a quarter of a century.
Dr Sujoy Kumar Guha, who developed the polymer that is the crux of the entire contraceptive treatment, has been working on it for about 37 years.
Just seven percent of the contraceptive-using population prevents pregnancy via male sterilization. This implies that in the US and India, women have been responsible for contraception. The side effects of the pill, which is the most popular female contraceptives include; spotting, weight gain, mood swings, nausea, acne, breast swelling and tenderness and breakthrough bleeding between periods.
Male contraceptives had in the past gotten to clinical trials a few times in the US but failed or been called off because the side effects were unbearable for the men. The side effects were similar to those women experience while on birth control.
But with regards to this latest male contraceptive, the Indian Council of Medical Research (ICMR) has done something unprecedented: they have completed all 3 rounds of clinical trials with a large number of men.
According to the Hindustan Times, the new injection is 97.3 percent effective and the 303 male participants reported no side effects.